Updated sustainability report from NewAge® Industries showcases recent improvements
Includes upgrades such as an EV charging station, on-demand generators & new high-efficiency lighting...
List view / Grid view
News
What’s new at Lab Innovations 2017
Lab Innovations kicks off in only a few weeks on the 1st and 2nd of November at the NEC, Birmingham...
Ketamine may help treat migraine pain unresponsive to other therapies
Ketamine, a medication commonly used for pain relief and increasingly used for depression, may help alleviate migraine pain...
New vaccine offers hope for pneumonia
Scientists are developing a vaccine by targeting strains of S. pneumoniae...
Functionalizing liposomes could pave the way to personalised medicine
Researchers have shown a method to functionalize liposomes for specific targeting, potentially paving the way for personalised medicine...
Integrated lab-on-a-chip uses smartphone to detect multiple pathogens
Researchers have developed a platform to diagnose infectious diseases at the point-of-care, using a smartphone as the detection instrument...
CPhI Annual Report reveals slow and discouraging trends in current drug pipelines
CPhI Worldwide report states the current drugs pipeline is discouraging and slowing simple manufacturing innovations...
FDA approves Yescarta to treat adults with B-cell lymphoma
The FDA has approved Yescarta, a cell-based gene therapy, to treat adult patients with certain types of large B-cell lymphoma...
FDA accepts regulatory submission for Lynparza in metastatic breast cancer
Lynparza has the potential to offer a new treatment option for patients with metastatic breast cancer...
Revolade shows long-term disease control for immune thrombocytopenia
Novartis has announced long-term study results supporting the positive safety and efficacy of Revolade in adults with chronic/persistent immune thrombocytopenia...
Arsenic identified as a potential treatment for brain cancer
Arsenic trioxide could extend the survival of glioblastoma patients by three to four times the historic median...
Oral semaglutide shows promise for type 2 diabetes
Researchers have identified that the drug semaglutide resulted in better glycemic control than placebo for patients with type 2 diabetes...
DOACs used as a alternative to warfarin to treat venous thromboembolism
A study has found that a new group of drugs used to treat patients with serious blood clots are not associated with a higher risk of major bleeding compared with warfarin...
Flu vaccine found to be ineffective in leukaemia patients
Leukaemia patients who were vaccinated against influenza were just as likely as their unvaccinated peers to develop flu, suggesting that additional steps are necessary to protect high-risk individuals...
Macrophages play critical role in sustained delivery of MD therapy
Inflammatory cells retain drug after it disappears from circulation, improving delivery to regenerating muscle cells...
